| 2008 | A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer | 이경은 | Article |
| 2017 | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalanprednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma | 문영철 | Article |
| 2018 | Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey | 이순남 | Article |
| 2014 | Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea | 문영철 | Article |
| 2009 | Clinical features and survival outcomes in patients with multiple myeloma: Analysis of web-based data from the korean myeloma registry | 문영철 | Article |
| 2021 | Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone | 문영철 | Article |
| 2021 | Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia | 문영철 | Article |
| 2017 | Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy | 문영철 | Article |
| 2021 | Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia | 문영철 | Article |
| 2013 | Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment | 허정원; 문영철 | Article |
| 2017 | Improved prognostic stratification using NCCN- and GELTAMOinternational prognostic index in patients with diffuse large B-cell lymphoma | 문영철 | Article |
| 2017 | Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia | 문영철 | Article |
| 2013 | Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib | 문영철 | Article |
| 2012 | Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) | 문영철 | Article |
| 2018 | Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma | 문영철 | Article |
| 2012 | Surface-plasmon-enhanced band emission of ZnO nanoflowers decorated with Au nanoparticles | 김동하 | Article |
| 2020 | The Impacts of Prognostic Awareness on Mood and Quality of Life Among Patients With Advanced Cancer | 이순남 | Article |
| 2015 | Treatment outcomes of rituximab plus hyper-CVAD in korean patients with sporadic burkitt or burkitt-like lymphoma: Results of a multicenter analysis | 문영철 | Article |
| 2015 | Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL) | 문영철 | Article |
